Belimumab in early systemic lupus erythematosus: A propensity score matching analysis

Abstract Objective This study aimed to evaluate the clinical efficacy of belimumab in patients with early systemic lupus erythematosus (SLE), defined as having a disease duration of less than 6 months. Methods We retrospectively identified patients with SLE in the early stage who received belimumab...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chaofan Lu, Nan He, Lei Dou, Hongxia Yu, Mengtao Li, Xiaomei Leng, Xiaofeng Zeng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-08-01
coleção:	Immunity, Inflammation and Disease
Assuntos:	belimumab early medical intervention LLDAS lupus nephritis systemic lupus erythematosus
Acesso em linha:	https://doi.org/10.1002/iid3.1362
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!